CH Biotech R&D CoTPE:6534 +0.11%84 Shareholder Yield % is 5.16% as of Dec. 2025, which is 126% above its 10-year median of 2.28. GuruFocus rates TPE:6534 with a GF Score™ of 84/100 and a GF Value™ of NT$100.57 (Modestly Undervalued). The stock has 1 warning sign investors should review. Among 250 Agriculture companies, CH Biotech R&D Co ranks better than 76.8% on this metric.
Shareholder Yield % is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. It is a measure of shareholder return.
As of today, CH Biotech R&D Co's Shareholder Yield % was 5.16%.
CH Biotech R&D Co (TPE:6534) Shareholder Yield % Explanation
Shareholder Yield % is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. The term was coined by William W. Priest of Epoch Investment Partners in a paper in 2005 entitled The Case for Shareholder Yield as a Dominant Driver of Future Equity Returns. William Priest indicated that "shareholder yield is a term that we came up with to reflect the various ways dividends can be paid to owners of a business in a publicly-traded company."
Dividend Yield % shows how much a company pays out in dividends each year relative to its stock price, which is most obvious form of shareholder return.
Buyback Yield % is the net repurchase of shares outstanding over the market capital of the company. Shares repurchases also increase shareholder value by returning the money back to shareholders.
Net Debt Paydown Yield % is the change in average of four quarters of company's total debt over a company's market cap. Assuming the total value of a company remains that same, shareholder value is increased as debt is reduced.
CH Biotech R&D Co Shareholder Yield % Related Terms
CH Biotech R&D Co Shareholder Yield % Historical Data
* Premium members only.
The historical data trend for CH Biotech R&D Co's Shareholder Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TPE:6534 vs CTVA, CF, MOS: Shareholder Yield % Comparison
For the Agricultural Inputs subindustry, CH Biotech R&D Co's Shareholder Yield %, along with its competitors' market caps and Shareholder Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
CH Biotech R&D Co Shareholder Yield % vs Agriculture Industry
For the Agriculture industry and Basic Materials sector, CH Biotech R&D Co's Shareholder Yield % distribution charts can be found below:
* The bar in red indicates where CH Biotech R&D Co's Shareholder Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* All the data are calculated by TTM values. Note that if a companies is traded in several exchanges, then we calculate the company level data for Shareholder Yield % using the primary share class stock data. The calculation result in definition page is for demonstration purpose only, and it's showing the share class level data. Therefore, the numbers in the calculation may differ from elsewhere if the stock is not a primary share.
CH Biotech R&D Co (TPE:6534) has a Shareholder Yield % of 5.16% as of Dec. 2025. Shareholder Yield is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. View historical data on CH Biotech R&D Co and its competitors. This is 126% above median its historical median of 2.28. According to the industry distribution chart, CH Biotech R&D Co ranks #58 out of 250 companies in the Agriculture industry, placing it in the top 23.2%.
Is CH Biotech R&D Co's Shareholder Yield % too high?
CH Biotech R&D Co's current Shareholder Yield % of 5.16% is 126% above median its 10-year median of 2.28. Based on the distribution chart, CH Biotech R&D Co ranks #58 out of 250 companies in the Agriculture industry, which is in the top quartile — a strong position relative to peers. Overall, CH Biotech R&D Co has a GF Score™ of 84/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does CH Biotech R&D Co's Shareholder Yield % compare to CTVA and CF?
According to the Agriculture industry distribution chart, CH Biotech R&D Co ranks #58 out of 250 companies for Shareholder Yield %. This places CH Biotech R&D Co in the top 23% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Shareholder Yield % for an Agriculture company?
A good Shareholder Yield % depends on the Agriculture industry context. However, Shareholder Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Shareholder Yield % mean?
A high Shareholder Yield % can signal that a stock is expensive relative to its fundamentals. Shareholder Yield is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. View historical data on CH Biotech R&D Co and its competitors. CH Biotech R&D Co's current Shareholder Yield % is 5.16%, which is 126% above median its own 10-year median of 2.28. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CH Biotech R&D Co stock overvalued right now?
Based on GuruFocus' analysis, CH Biotech R&D Co (TPE:6534) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$100.57, compared to a current price of NT$90.20 — trading 10.3% below its estimated fair value. The current Shareholder Yield % is 5.16%, which is 126% above median its 10-year median of 2.28. CH Biotech R&D Co's overall GF Score™ is 84/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Shareholder Yield % calculated?
Shareholder Yield % is calculated from a company's financial statements. For CH Biotech R&D Co (TPE:6534), the current Shareholder Yield % is 5.16% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is CH Biotech R&D Co (TPE:6534) Overvalued in 2026?
Based on GuruFocus' analysis, CH Biotech R&D Co stock appears to be undervalued.
The current stock price of NT$90.20 is trading 10.3% below its estimated GF Value™ of NT$100.57.
GuruFocus considers CH Biotech R&D Co to be Modestly Undervalued.
Key valuation signals for TPE:6534:
Shareholder Yield %: 5.16% (126% above median its 10-year median of 2.28)
GF Value™: NT$100.57 vs. price of NT$90.20 (10.3% below fair value)
No single metric tells the full story. See the TPE:6534 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
CH Biotech R&D Co Ltd is a Taiwan-based company engaged in the manufacture and sales of fertilizer, as well as providing biotechnology services. It is engaged in the research, development, manufacturing, and sales of proprietary plant growth regulators and specialty micronutrient fertilizers. It offers NutriSync 3D plant growers in the form of boron and molybdenum, NutriSync D liquid formulation for dicot crops, CHB-HS for reducing carbon emissions in crop production, CHB-BB2, fruit quality enhancers, and other related products. The company has one reportable segment, Agricultural Biotechnology. Geographically, it derives maximum revenue from the United States, and the rest from other countries.
84GF Score
Get the complete analysis for TPE:6534
Shareholder Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TPE:6534 has been successfully added to your 
